FDA leadership shakeup continues with departure of top drug regulator

Dr. Tracy Beth Høeg is leaving her role as head of the FDA division that regulates over-the-counter and prescription drugs, according to a Department of Health and Human Services official

Dr. Tracy Beth Høeg is leaving her role as head of the FDA division that regulates over-the-counter and prescription drugs, according to a Department of Health and Human Services official.

Subscribe to read this story ad-free

Get unlimited access to ad-free articles and exclusive content.

Høeg, a sports medicine doctor who criticized Covid shots for children during the pandemic, served as acting director of the Food and Drug Administration’s Center for Drug Evaluation and Research for about five months.

She was the fifth person to hold the post under the second Trump administration and the right hand to former FDA Commissioner Marty Makary, who resigned Tuesday after opposing the Trump administration’s moves to expand access to flavored e-cigarettes. Høeg was previously a special assistant to Makary.